Looks like one of your shorter friends have arrived in a...

Looks like one of your shorter friends have arrived in a desperate attempt to downplay what are clearly incredibly impressive results indicating the potential for Scenesse to be used to both prevent and reverse the cancerous effects of sun exposure, in addition to providing a highly desirable bronzing effect.

Seems that the market may finally be realising how mispriced this company currently is, and how incorrect the view of this company espoused by the shorters is as well. However I won't be satisfied that this is fairly valued until it is priced at a market capitalisation in the tens of billions of dollars (where a company of such high quality and with such an enormous pipeline deserves to be priced). There's a lot more ground to make up for...